"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","43/77","481/2914",1.48007685964942e-15,9.5316949761423e-13,5.96704670784979e-13,"CCNH/CDK1/CDK2/CSNK2A1/CTNNB1/RARA/SIRT1/SMAD3/AR/ATR/BCL6/EP300/MAX/SMAD2/SMAD4/SMAD7/TP53/UBE2I/CREBBP/GSK3B/MAPK1/MAPK14/PRKACA/ESR1/MDM2/RB1/SUMO1/CAMK2A/CREB1/FBXW7/SGK1/RUNX2/MYBL2/TCF7/KMT2A/FOXO4/SMAD1/FOXO3/MAF/E2F4/YY1/GATA2/JUNB",43
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","43/77","499/2914",6.03438080515362e-15,1.94307061925947e-12,1.21640413072307e-12,"CCNH/CDK1/CDK2/CSNK2A1/CTNNB1/RARA/SIRT1/SMAD3/AR/ATR/BCL6/EP300/MAX/SMAD2/SMAD4/SMAD7/TP53/UBE2I/CREBBP/GSK3B/MAPK1/MAPK14/PRKACA/ESR1/MDM2/RB1/SUMO1/CAMK2A/CREB1/FBXW7/SGK1/RUNX2/MYBL2/TCF7/KMT2A/FOXO4/SMAD1/FOXO3/MAF/E2F4/YY1/GATA2/JUNB",43
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","34/77","397/2914",3.00956358846904e-11,6.4605298365802e-09,4.04443106801278e-09,"CDK2/CSNK2A1/CTNNB1/MAP2K1/RARA/SMAD3/EP300/NCOA2/PAX6/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/SMAD2/SMAD4/CREBBP/GSK3B/MAPK1/MAPK14/PRKACA/STAT3/CREB1/GRB2/HRAS/MAPK8/PLCG1/RASA1/SHC1/CEBPA/TCF4/KMT2A/FOXO3/YY1/GATA2",34
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","13/77","70/2914",1.55863895558552e-08,2.50940871849269e-06,1.57094399997172e-06,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAPK1/MAPK14/STAT3/CREB1/GRB2/HRAS/PLCG1/SHC1/ELK1",13
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","8/77","27/2914",2.43873442589556e-07,3.14108994055349e-05,1.96639007393263e-05,"CDK2/RARA/EP300/STAT3/CREB1/CEBPA/KMT2A/GATA2",8
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","13/77","89/2914",3.09904763318358e-07,3.32631112628371e-05,2.08234253247248e-05,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAPK1/MAPK14/STAT3/CREB1/GRB2/HRAS/PLCG1/SHC1/ELK1",13
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","11/77","62/2914",3.65254937175246e-07,3.36034542201226e-05,2.10364873591157e-05,"CDK1/AR/SMAD4/GSK3B/MAPK1/ESR1/RB1/FBXW7/RUNX2/SMAD1/MAF",11
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","14/77","108/2914",4.73884669228219e-07,3.81477158728716e-05,2.38812931992642e-05,"EP300/NCOA2/CREBBP/MAPK1/ESR1/CREB1/HRAS/SHC1/ELK1/FOXA1/FOXO3/YY1/SRF/USF1",14
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","8/77","30/2914",6.03061446524025e-07,4.31523968401636e-05,2.70143314641756e-05,"RPS6KA1/RPS6KA2/RPS6KA5/MAPK1/MAPK14/CREB1/MAPK8/ELK1",8
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","18/77","187/2914",8.67515362002481e-07,5.58679893129598e-05,3.4974566699679e-05,"CDK2/SIRT1/AR/ATR/EP300/RPS6KA1/RPS6KA2/TP53/CREBBP/GSK3B/MAPK1/MAPK14/STAT3/MDM2/RB1/CAMK2A/MAPK8/ETS2",18
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","18/77","189/2914",1.01797713564342e-06,5.95979341231241e-05,3.73095926269313e-05,"CDK2/SIRT1/AR/ATR/EP300/RPS6KA1/RPS6KA2/TP53/CREBBP/GSK3B/MAPK1/MAPK14/STAT3/MDM2/RB1/CAMK2A/MAPK8/ETS2",18
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","15/77","136/2914",1.48367976544202e-06,7.58607512840886e-05,4.74904670510068e-05,"RARA/EP300/NCOA2/CREBBP/MAPK1/ESR1/CREB1/HRAS/SHC1/ELK1/FOXA1/FOXO3/YY1/SRF/USF1",15
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","7/77","24/2914",1.64914676704541e-06,7.58607512840886e-05,4.74904670510068e-05,"RPS6KA1/RPS6KA2/RPS6KA5/MAPK1/MAPK14/CREB1/ELK1",7
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","7/77","24/2914",1.64914676704541e-06,7.58607512840886e-05,4.74904670510068e-05,"AR/SMAD4/MAPK1/RB1/RUNX2/SMAD1/MAF",7
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","7/77","25/2914",2.24226274261377e-06,9.44001905069352e-05,5.90965560054858e-05,"EP300/UBE2I/CREBBP/ESR1/SUMO1/MYBL2/YY1",7
"R-HSA-450294","R-HSA-450294","MAP kinase activation","10/77","60/2914",2.38451083663467e-06,9.44001905069352e-05,5.90965560054858e-05,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",10
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","5/77","10/2914",2.57120221994337e-06,9.44001905069352e-05,5.90965560054858e-05,"SIRT1/EP300/CREBBP/FOXO4/FOXO3",5
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","14/77","124/2914",2.63851464149819e-06,9.44001905069352e-05,5.90965560054858e-05,"CDK1/SMAD3/AR/EP300/SMAD2/SMAD4/SMAD7/TP53/MAP3K7/ESR1/MDM2/FOXO4/SMAD1/YY1",14
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","21/77","268/2914",2.79237413360152e-06,9.46467864231252e-05,5.92509303694948e-05,"CTNNB1/MAP2K1/SMAD3/EP300/SMAD2/SMAD4/CREBBP/GSK3B/MAPK1/STAT3/ESR1/MDM2/CAMK2A/CREB1/GRB2/HRAS/PLCG1/SHC1/FBXW7/FOXO4/FOXO3",21
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","9/77","49/2914",3.4247544153885e-06,0.000108335457396839,6.78203337414013e-05,"SIRT1/SMAD3/BCL6/EP300/SMAD2/SMAD4/CREBBP/FOXO4/FOXO3",9
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","11/77","78/2914",3.97866186730172e-06,0.000108335457396839,6.78203337414013e-05,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","11/77","78/2914",3.97866186730172e-06,0.000108335457396839,6.78203337414013e-05,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","11/77","78/2914",3.97866186730172e-06,0.000108335457396839,6.78203337414013e-05,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","6/77","18/2914",4.03734623839151e-06,0.000108335457396839,6.78203337414013e-05,"RPS6KA1/RPS6KA2/MAPK1/CREB1/GRB2/HRAS",6
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","10/77","64/2914",4.39893567267499e-06,0.000113316582928108,7.09386257951377e-05,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",10
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","9/77","53/2914",6.78248272393026e-06,0.00016799687977735,0.000105169671387259,"CTNNB1/SMAD3/EP300/SMAD4/TP53/CREBBP/MDM2/TCF7/FOXO3",9
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","11/77","83/2914",7.42289311121632e-06,0.000177049746800863,0.000110836961465725,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","11/77","84/2914",8.361494474719e-06,0.00018328213049467,0.000114738568125954,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","11/77","84/2914",8.361494474719e-06,0.00018328213049467,0.000114738568125954,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","7/77","30/2914",8.53798744540387e-06,0.00018328213049467,0.000114738568125954,"MAP3K1/MAPK1/GRB2/HRAS/MAPK8/PLCG1/SHC1",7
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","11/77","86/2914",1.05539096974267e-05,0.000205961146822509,0.000128936121662342,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","11/77","86/2914",1.05539096974267e-05,0.000205961146822509,0.000128936121662342,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","11/77","86/2914",1.05539096974267e-05,0.000205961146822509,0.000128936121662342,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","6/77","21/2914",1.10774182648616e-05,0.000209819334193262,0.000131351430199443,"RPS6KA1/RPS6KA2/RPS6KA5/MAPK1/MAPK14/ELK1",6
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","11/77","87/2914",1.18268706384211e-05,0.000211569574753978,0.000132447118553079,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","11/77","87/2914",1.18268706384211e-05,0.000211569574753978,0.000132447118553079,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","5/77","13/2914",1.23370849819337e-05,0.000214731965631494,0.000134426843473132,"BCL6/EP300/CREBBP/FOXO4/FOXO3",5
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","6/77","22/2914",1.49134679189712e-05,0.000252744035258354,0.000158223219195733,"RPS6KA1/RPS6KA2/MAPK1/CAMK2A/CREB1/HRAS",6
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","5/77","14/2914",1.8796206661624e-05,0.000310378386925279,0.00019430356683946,"SMAD3/SMAD2/SMAD4/FOXO4/FOXO3",5
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","6/77","24/2914",2.57914730965178e-05,0.000415242716853936,0.00025995089989385,"SMAD3/SMAD2/SMAD4/SMAD7/E2F4/JUNB",6
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","10/77","80/2914",3.39805955087211e-05,0.000533743987990644,0.000334135252370736,"SMAD3/AR/SMAD2/SMAD4/SMAD7/TP53/MAP3K7/MDM2/FOXO4/SMAD1",10
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","5/77","16/2914",3.93407148819699e-05,0.000603224294856872,0.000377631423553746,"TP53/UBE2I/MDM2/PIAS1/SUMO1",5
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","11/77","99/2914",4.12190310093027e-05,0.000617326883023045,0.000386459948018677,"CDK2/RPS6KA1/RPS6KA2/TP53/MAPK1/MAPK14/STAT3/MDM2/RB1/MAPK8/ETS2",11
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","6/77","28/2914",6.63538853597286e-05,0.000971179594810573,0.000607979380209953,"RARA/AR/UBE2I/ESR1/PIAS1/SUMO1",6
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","10/77","87/2914",7.10969091639947e-05,0.0010174757667025,0.000636961782685613,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",10
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","11/77","107/2914",8.54210584328366e-05,0.00119589481805971,0.000748655958347286,"RARA/AR/EP300/NCOA2/TP53/UBE2I/CREBBP/ESR1/MDM2/PIAS1/SUMO1",11
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","10/77","90/2914",9.53460513948857e-05,0.00121871150219105,0.00076293969489894,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",10
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","10/77","90/2914",9.53460513948857e-05,0.00121871150219105,0.00076293969489894,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",10
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","5/77","19/2914",9.84052765744325e-05,0.00121871150219105,0.00076293969489894,"CDK1/CDK2/MAX/MYBL2/E2F4",5
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","5/77","19/2914",9.84052765744325e-05,0.00121871150219105,0.00076293969489894,"EP300/RPS6KA5/CREBBP/PRKACA/HRAS",5
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","5/77","19/2914",9.84052765744325e-05,0.00121871150219105,0.00076293969489894,"AR/MAPK1/RB1/RUNX2/MAF",5
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","5/77","19/2914",9.84052765744325e-05,0.00121871150219105,0.00076293969489894,"SMAD3/SMAD2/SMAD4/FOXO4/FOXO3",5
"R-HSA-2990846","R-HSA-2990846","SUMOylation","11/77","109/2914",0.000101361536492292,0.00123163829247238,0.000771032144519325,"RARA/AR/EP300/NCOA2/TP53/UBE2I/CREBBP/ESR1/MDM2/PIAS1/SUMO1",11
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","11/77","110/2914",0.00011024454343346,0.00131476825872497,0.000823073296978857,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","5/77","20/2914",0.000128513308734058,0.00150477401499515,0.000942020999907068,"RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/MAPK1",5
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","6/77","33/2914",0.00017557472589101,0.00201910934774662,0.00126400601534318,"MAP2K1/MAPK1/MAPK14/GRB2/HRAS/SHC1",6
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","17/77","249/2914",0.000180628873531653,0.00204061887834968,0.0012774714455834,"CCNH/CDK1/CDK2/CSNK2A1/ATR/EP300/MAX/TP53/UBE2I/GSK3B/MAPK1/PRKACA/MDM2/RB1/SUMO1/MYBL2/E2F4",17
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","7/77","47/2914",0.000183782445565654,0.00204061887834968,0.0012774714455834,"RPS6KA1/RPS6KA2/MAPK1/PRKACA/CAMK2A/CREB1/HRAS",7
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","8/77","63/2914",0.000197305724760792,0.00215364214823645,0.00134822645108624,"MAPK1/ESR1/CREB1/HRAS/SHC1/ELK1/FOXO3/SRF",8
"R-HSA-422475","R-HSA-422475","Axon guidance","17/77","254/2914",0.000230667153650967,0.00245929784641432,0.00153957351287461,"CSNK2A1/MAP2K1/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/GSK3B/MAPK1/MAPK14/PRKACA/CREB1/GRB2/HRAS/MAPK8/PLCG1/RASA1/SHC1",17
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","7/77","49/2914",0.000240583484975314,0.00245929784641432,0.00153957351287461,"SIRT1/ATR/EP300/CREBBP/GSK3B/MAPK1/CAMK2A",7
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","7/77","49/2914",0.000240583484975314,0.00245929784641432,0.00153957351287461,"RPS6KA1/RPS6KA2/MAPK1/PRKACA/CAMK2A/CREB1/HRAS",7
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","7/77","49/2914",0.000240583484975314,0.00245929784641432,0.00153957351287461,"EP300/NCOA2/CREBBP/ESR1/FOXA1/YY1/USF1",7
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","5/77","23/2914",0.000262101257550623,0.00263739390410315,0.00165106548753107,"TP53/MAPK1/MDM2/RB1/ETS2",5
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","6/77","36/2914",0.000289879487605084,0.00287203676950268,0.00179795698385016,"SMAD3/SMAD2/SMAD4/SMAD7/E2F4/JUNB",6
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","5/77","24/2914",0.000324288042933283,0.00311703730819454,0.00195133260712408,"GSK3B/MDM2/CREB1/FOXO4/FOXO3",5
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","5/77","24/2914",0.000324288042933283,0.00311703730819454,0.00195133260712408,"MAPK1/CREB1/ELK1/FOXO3/SRF",5
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","6/77","37/2914",0.000338783787209693,0.0032084817494565,0.00200857880032991,"EP300/NCOA2/UBE2I/CREBBP/PIAS1/SUMO1",6
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","4/77","14/2914",0.000369110652609981,0.00339581800401182,0.00212585533758831,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","4/77","14/2914",0.000369110652609981,0.00339581800401182,0.00212585533758831,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","9/77","87/2914",0.000379515661672635,0.00344236741010109,0.0021549962701352,"MAP3K1/MAP3K7/MAPK1/GRB2/HRAS/MAPK8/PLCG1/SHC1/NFATC1",9
"R-HSA-373760","R-HSA-373760","L1CAM interactions","7/77","53/2914",0.000396571668734045,0.00352830530328552,0.00220879524543699,"CSNK2A1/MAP2K1/RPS6KA1/RPS6KA2/RPS6KA4/RPS6KA5/MAPK1",7
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","11/77","127/2914",0.000399947650838265,0.00352830530328552,0.00220879524543699,"MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAP3K1/MAP3K7/MAPK1/MAPK14/CREB1/MAPK8/ELK1",11
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","4/77","15/2914",0.000493291083794433,0.00423572610618154,0.00265165593113359,"SMAD3/SMAD2/SMAD4/FOXO3",4
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","4/77","15/2914",0.000493291083794433,0.00423572610618154,0.00265165593113359,"CDK1/EP300/TP53/E2F4",4
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","5/77","27/2914",0.00057885406556326,0.00484132491198363,0.00303077384977073,"RARA/EP300/PAX6/CREBBP/YY1",5
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","5/77","27/2914",0.00057885406556326,0.00484132491198363,0.00303077384977073,"RARA/EP300/PAX6/CREBBP/YY1",5
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","4/77","16/2914",0.000644607873431922,0.00518909338112697,0.00324848441479508,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","4/77","16/2914",0.000644607873431922,0.00518909338112697,0.00324848441479508,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","4/77","16/2914",0.000644607873431922,0.00518909338112697,0.00324848441479508,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","5/77","28/2914",0.000690267148216203,0.00547222958673162,0.00342573378835928,"SMAD3/PPP1CA/SMAD2/SMAD4/SMAD7",5
"R-HSA-1643685","R-HSA-1643685","Disease","23/77","443/2914",0.000696774574708063,0.00547222958673162,0.00342573378835928,"CCNH/CTNNB1/MAP2K1/SMAD3/EP300/SMAD2/SMAD4/CREBBP/GSK3B/MAPK1/PRKACA/STAT3/ESR1/MDM2/CAMK2A/CREB1/GRB2/HRAS/PLCG1/SHC1/FBXW7/FOXO4/FOXO3",23
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","19/77","332/2914",0.000711901815416046,0.00552367191720402,0.00345793779713818,"MAP2K1/SMAD3/BCL6/RPS6KA1/RPS6KA2/RPS6KA5/TP53/MAP3K7/MAPK1/MAPK14/PRKACA/STAT3/CREB1/GRB2/MAPK8/SHC1/ELK1/FOXO3/JUNB",19
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","9/77","95/2914",0.000732681238518861,0.0056172228286446,0.00351650268612436,"CDK1/CDK2/CSNK2A1/ATR/EP300/TP53/MAPK14/MDM2/SGK1",9
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","8/77","77/2914",0.000795249902497662,0.00597800363301426,0.00374235925375035,"RPS6KA1/RPS6KA2/MAPK1/PRKACA/MDM2/CAMK2A/CREB1/HRAS",8
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","5/77","29/2914",0.000817006285551479,0.00597800363301426,0.00374235925375035,"STAT3/GRB2/HRAS/PLCG1/RASA1",5
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","5/77","29/2914",0.000817006285551479,0.00597800363301426,0.00374235925375035,"CDK1/CDK2/TP53/MDM2/SGK1",5
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","5/77","29/2914",0.000817006285551479,0.00597800363301426,0.00374235925375035,"CDK1/CDK2/TP53/MDM2/SGK1",5
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","4/77","17/2914",0.000826152675991101,0.00597800363301426,0.00374235925375035,"UBE2I/MDM2/PIAS1/SUMO1",4
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","21/77","393/2914",0.000879143499252208,0.00629076015020469,0.00393815158144556,"CDK1/RARA/SMAD3/AR/EP300/NCOA2/SMAD2/SMAD4/SMAD7/TP53/UBE2I/CREBBP/MAP3K7/ESR1/MDM2/PIAS1/SUMO1/FBXW7/FOXO4/SMAD1/YY1",21
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","5/77","30/2914",0.000960354619782328,0.00679635577076724,0.0042546653484862,"CDK1/CDK2/EP300/TP53/E2F4",5
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","7/77","63/2914",0.00115142792762654,0.00805999549338578,0.00504573107872958,"SMAD3/PPP1CA/SMAD2/SMAD4/SMAD7/E2F4/JUNB",7
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","13/77","191/2914",0.0012071816603298,0.00835940848658489,0.00523317007251064,"CCNH/CDK1/CDK2/CSNK2A1/EP300/MAX/TP53/GSK3B/MAPK1/PRKACA/RB1/MYBL2/E2F4",13
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","5/77","32/2914",0.00130216777654397,0.00892123455419488,0.00558488531261301,"RPS6KA5/MAPK1/CREB1/GRB2/HRAS",5
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","13/77","194/2914",0.00139567742021737,0.00946122377494722,0.0059229302154377,"CCNH/CDK1/CDK2/CSNK2A1/ATR/BCL6/EP300/TP53/CREBBP/MAPK14/MDM2/SGK1/E2F4",13
"R-HSA-69275","R-HSA-69275","G2/M Transition","7/77","66/2914",0.00152094863167715,0.0102030304041675,0.00638731717031084,"CCNH/CDK1/CDK2/EP300/TP53/PRKACA/MYBL2",7
"R-HSA-167044","R-HSA-167044","Signalling to RAS","4/77","20/2914",0.00158339116411871,0.0105124114401283,0.00658099637392801,"MAPK14/GRB2/HRAS/SHC1",4
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","8/77","86/2914",0.0016552687923643,0.0107676070937637,0.00674075435912307,"CCNH/CSNK2A1/EP300/CREBBP/ESR1/RUNX2/KMT2A/GATA2",8
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","8/77","86/2914",0.0016552687923643,0.0107676070937637,0.00674075435912307,"SMAD3/PPP1CA/SMAD2/SMAD4/SMAD7/SMAD1/E2F4/JUNB",8
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","7/77","68/2914",0.00181476756987996,0.0116476192650051,0.00729166096517971,"CCNH/CDK1/CDK2/EP300/TP53/PRKACA/MYBL2",7
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","3/77","10/2914",0.00186289562778808,0.0116476192650051,0.00729166096517971,"CDK1/MYBL2/E2F4",3
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/77","10/2914",0.00186289562778808,0.0116476192650051,0.00729166096517971,"MAPK1/MAPK14/MAPK8",3
"R-HSA-74749","R-HSA-74749","Signal attenuation","3/77","10/2914",0.00186289562778808,0.0116476192650051,0.00729166096517971,"MAPK1/GRB2/SHC1",3
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","8/77","88/2914",0.0019215241996414,0.0118563049109886,0.00742230268209978,"RPS6KA1/RPS6KA2/MAPK1/PRKACA/MDM2/CAMK2A/CREB1/HRAS",8
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","13/77","201/2914",0.00193309319200901,0.0118563049109886,0.00742230268209978,"CSNK2A1/TP53/GSK3B/MAPK1/PRKACA/ESR1/MDM2/CAMK2A/CREB1/GRB2/PLCG1/FOXO4/FOXO3",13
"R-HSA-400253","R-HSA-400253","Circadian Clock","6/77","52/2914",0.00216531968548722,0.013155338466545,0.00823552571540818,"SIRT1/EP300/NCOA2/PPP1CA/CREBBP/CREB1",6
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","4/77","22/2914",0.00229656101590923,0.0135686724242711,0.00849428169090522,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","4/77","22/2914",0.00229656101590923,0.0135686724242711,0.00849428169090522,"CTNNB1/EP300/CREBBP/TCF7",4
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","4/77","22/2914",0.00229656101590923,0.0135686724242711,0.00849428169090522,"SMAD3/PPP1CA/SMAD2/SMAD7",4
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","3/77","11/2914",0.00251300224028553,0.0144899506256795,0.00907102172218903,"SMAD2/SMAD4/STAT3",3
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","3/77","11/2914",0.00251300224028553,0.0144899506256795,0.00907102172218903,"GRB2/HRAS/PLCG1",3
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","7/77","72/2914",0.00253371890523112,0.0144899506256795,0.00907102172218903,"EP300/RPS6KA5/CREBBP/MAP3K7/PRKACA/HRAS/NFATC1",7
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","5/77","37/2914",0.00254249133649345,0.0144899506256795,0.00907102172218903,"MAPK1/GRB2/HRAS/PLCG1/SHC1",5
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","5/77","38/2914",0.00286803033838625,0.016201855595796,0.0101427111689929,"MAPK1/GRB2/HRAS/PLCG1/SHC1",5
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","6/77","55/2914",0.00289553692558125,0.016215006783255,0.0101509440960881,"CCNH/EP300/UBE2I/PIAS1/SUMO1/YY1",6
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","6/77","56/2914",0.00317581672382891,0.0172954757303476,0.0108273409688185,"CDK2/CSNK2A1/ATR/TP53/MAPK14/MDM2",6
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","4/77","24/2914",0.00320498439156343,0.0172954757303476,0.0108273409688185,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","4/77","24/2914",0.00320498439156343,0.0172954757303476,0.0108273409688185,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","4/77","24/2914",0.00320498439156343,0.0172954757303476,0.0108273409688185,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","5/77","39/2914",0.00322275945285981,0.0172954757303476,0.0108273409688185,"CCNH/CDK2/MAX/RB1/E2F4",5
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/77","12/2914",0.00328732258606989,0.0174961631853637,0.0109529756456265,"SMAD3/SMAD2/SMAD4",3
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","5/77","40/2914",0.00360813011230731,0.0188913479050887,0.0118263913822311,"CTNNB1/MAP3K7/CAMK2A/NFATC1/TCF7",5
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","5/77","40/2914",0.00360813011230731,0.0188913479050887,0.0118263913822311,"CCNH/CDK2/MAX/RB1/E2F4",5
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","7/77","77/2914",0.00372108324987699,0.0191146787907509,0.011966201335171,"CCNH/CDK1/CDK2/MAX/RB1/MYBL2/E2F4",7
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","4/77","25/2914",0.00373982845905997,0.0191146787907509,0.011966201335171,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","4/77","25/2914",0.00373982845905997,0.0191146787907509,0.011966201335171,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","5/77","41/2914",0.00402559264527412,0.020413241445327,0.0127791295743057,"MAPK1/GRB2/HRAS/PLCG1/SHC1",5
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","3/77","13/2914",0.00419281311861772,0.0209315631658125,0.0131036101544723,"EP300/NCOA2/CREBBP",3
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","3/77","13/2914",0.00419281311861772,0.0209315631658125,0.0131036101544723,"EP300/TP53/MDM2",3
"R-HSA-111996","R-HSA-111996","Ca-dependent events","4/77","26/2914",0.00433224833306097,0.0211361206552369,0.0132316675563186,"MAPK1/PRKACA/CAMK2A/CREB1",4
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","4/77","26/2914",0.00433224833306097,0.0211361206552369,0.0132316675563186,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","4/77","26/2914",0.00433224833306097,0.0211361206552369,0.0132316675563186,"GSK3B/ESR1/FBXW7/RUNX2",4
"R-HSA-69206","R-HSA-69206","G1/S Transition","6/77","60/2914",0.00450378102587914,0.02180778180952,0.0136521419304449,"CCNH/CDK1/CDK2/MAX/RB1/E2F4",6
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","7/77","80/2914",0.00461345252159361,0.0221721151037782,0.0138802224333885,"CDK1/NCOA2/CREBBP/MAPK14/PRKACA/CREB1/SMO",7
"R-HSA-1250347","R-HSA-1250347","SHC1 events in ERBB4 signaling","3/77","14/2914",0.00523564106389256,0.0244329916314986,0.0152955799196861,"GRB2/HRAS/SHC1",3
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","3/77","14/2914",0.00523564106389256,0.0244329916314986,0.0152955799196861,"GRB2/HRAS/SHC1",3
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","3/77","14/2914",0.00523564106389256,0.0244329916314986,0.0152955799196861,"STAT3/GRB2/SHC1",3
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","3/77","14/2914",0.00523564106389256,0.0244329916314986,0.0152955799196861,"GRB2/HRAS/SHC1",3
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","5/77","44/2914",0.00548495513717359,0.0254123101319409,0.015908654430424,"TP53/MAPK1/MAPK14/MDM2/MAPK8",5
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","4/77","28/2914",0.00570080345437521,0.026223695890126,0.0164165994212459,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-112316","R-HSA-112316","Neuronal System","8/77","105/2914",0.00580407210728794,0.0265093789864783,0.016595443203369,"RPS6KA1/RPS6KA2/MAPK1/PRKACA/MDM2/CAMK2A/CREB1/HRAS",8
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/77","45/2914",0.0060451620479378,0.0274160870343094,0.0171630620041525,"CDK2/RPS6KA1/RPS6KA2/MAPK1/STAT3",5
"R-HSA-168249","R-HSA-168249","Innate Immune System","20/77","428/2914",0.00611455813286809,0.0275368911717975,0.0172386880006513,"CTNNB1/MAP2K1/EP300/RPS6KA1/RPS6KA2/RPS6KA5/CREBBP/MAP3K1/MAP3K7/MAPK1/MAPK14/PRKACA/CREB1/GRB2/HRAS/MAPK8/PLCG1/SHC1/NFATC1/ELK1",20
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","4/77","29/2914",0.00648221100138701,0.0289898880895363,0.0181482954205499,"GRB2/PLCG1/SHC1/NFATC1",4
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","5/77","46/2914",0.00664459282456036,0.0295111570966681,0.0184746210657468,"CCNH/UBE2I/PIAS1/SUMO1/YY1",5
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","4/77","30/2914",0.00733172736778773,0.0316888082205053,0.0198378776535691,"PRKACA/CAMK2A/CREB1/PLCG1",4
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","4/77","30/2914",0.00733172736778773,0.0316888082205053,0.0198378776535691,"CSNK2A1/TP53/STAT3/FBXW7",4
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","4/77","30/2914",0.00733172736778773,0.0316888082205053,0.0198378776535691,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","4/77","30/2914",0.00733172736778773,0.0316888082205053,0.0198378776535691,"CCNH/UBE2I/PIAS1/SUMO1",4
"R-HSA-73894","R-HSA-73894","DNA Repair","10/77","157/2914",0.00742970799996511,0.0318982130131835,0.019968969571836,"CCNH/CDK2/ATR/EP300/TP53/UBE2I/PIAS1/SUMO1/MAPK8/YY1",10
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","17/77","347/2914",0.00753115804427514,0.0321196409305509,0.0201075882255656,"CTNNB1/MAP2K1/RPS6KA1/RPS6KA2/RPS6KA5/MAPK1/MAPK14/PRKACA/STAT3/ESR1/CREB1/GRB2/HRAS/PLCG1/RASA1/SHC1/ELK1",17
"R-HSA-391251","R-HSA-391251","Protein folding","4/77","31/2914",0.00825174220287497,0.0347328233898789,0.021743496826289,"CSNK2A1/TP53/STAT3/FBXW7",4
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","4/77","31/2914",0.00825174220287497,0.0347328233898789,0.021743496826289,"STAT3/GRB2/HRAS/PLCG1",4
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","5/77","49/2914",0.00869195510685713,0.0363481759014025,0.022754742350829,"STAT3/GRB2/HRAS/PLCG1/RASA1",5
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","3/77","17/2914",0.00923889676987235,0.037680271049835,0.0235886626546041,"GRB2/HRAS/SHC1",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/77","17/2914",0.00923889676987235,0.037680271049835,0.0235886626546041,"SMAD3/EP300/CREBBP",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","4/77","32/2914",0.00924453854949369,0.037680271049835,0.0235886626546041,"SIRT1/ATR/GSK3B/MAPK1",4
"R-HSA-8853659","R-HSA-8853659","RET signaling","4/77","32/2914",0.00924453854949369,0.037680271049835,0.0235886626546041,"PRKACA/GRB2/PLCG1/SHC1",4
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","5/77","50/2914",0.00946189668420762,0.0383236570102497,0.0239914361473123,"MAPK1/GRB2/HRAS/PLCG1/SHC1",5
"R-HSA-69242","R-HSA-69242","S Phase","6/77","71/2914",0.0102409342920157,0.041219760525363,0.025804459433171,"CCNH/CDK2/MAX/GSK3B/RB1/E2F4",6
"R-HSA-5654704","R-HSA-5654704","SHC-mediated cascade:FGFR3","3/77","18/2914",0.0108784671238266,0.0429799559984314,0.0269063797767232,"GRB2/HRAS/SHC1",3
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/77","18/2914",0.0108784671238266,0.0429799559984314,0.0269063797767232,"CCNH/CDK1/CDK2",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/77","18/2914",0.0108784671238266,0.0429799559984314,0.0269063797767232,"EP300/CREBBP/IKZF1",3
"R-HSA-112040","R-HSA-112040","G-protein mediated events","4/77","34/2914",0.0114570546352825,0.0444478505127828,0.027825313413527,"MAPK1/PRKACA/CAMK2A/CREB1",4
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","4/77","34/2914",0.0114570546352825,0.0444478505127828,0.027825313413527,"MAPK1/PRKACA/CAMK2A/CREB1",4
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","4/77","34/2914",0.0114570546352825,0.0444478505127828,0.027825313413527,"TP53/UBE2I/SUMO1/MAPK8",4
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","3/77","19/2914",0.0126758517858487,0.0480377744029423,0.0300726832238099,"EP300/CREBBP/CAMK2A",3
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","3/77","19/2914",0.0126758517858487,0.0480377744029423,0.0300726832238099,"HRAS/PLCG1/RASA1",3
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","3/77","19/2914",0.0126758517858487,0.0480377744029423,0.0300726832238099,"GRB2/HRAS/SHC1",3
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","4/77","35/2914",0.0126807789572984,0.0480377744029423,0.0300726832238099,"TP53/UBE2I/SUMO1/MAPK8",4
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","7/77","97/2914",0.0130335450801876,0.0490853978458526,0.0307285181022582,"GSK3B/ESR1/MDM2/CREB1/GRB2/FOXO4/FOXO3",7
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","10/77","172/2914",0.0137720506551732,0.0512670556181016,0.0320942829384323,"CSNK2A1/TP53/GSK3B/MAPK1/ESR1/MDM2/CREB1/GRB2/FOXO4/FOXO3",10
"R-HSA-195721","R-HSA-195721","Signaling by WNT","10/77","172/2914",0.0137720506551732,0.0512670556181016,0.0320942829384323,"CSNK2A1/CTNNB1/EP300/CREBBP/GSK3B/MAP3K7/CAMK2A/NFATC1/TCF7/SOX6",10
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","5/77","55/2914",0.0140249805809987,0.0519085488170297,0.0324958715216122,"MAPK1/GRB2/HRAS/PLCG1/SHC1",5
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/77","20/2914",0.0146333448367422,0.0535447390617159,0.0335201619167002,"SMAD3/SMAD2/SMAD4",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/77","20/2914",0.0146333448367422,0.0535447390617159,0.0335201619167002,"CSNK2A1/MAP2K1/MAPK1",3
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","4/77","37/2914",0.0153722955617756,0.0559308380891722,0.0350139113895929,"CCNH/SIRT1/EP300/GSK3B",4
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","3/77","21/2914",0.0167527222472927,0.060598549266528,0.0379359992956525,"GRB2/HRAS/SHC1",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","4/77","38/2914",0.0168433855880567,0.060598549266528,0.0379359992956525,"NCOA2/CREBBP/MAPK14/CREB1",4
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","7/77","104/2914",0.0186012286313385,0.0645195603647941,0.0403906368416413,"SMAD3/EP300/TP53/CREBBP/CREB1/FBXW7/IKZF1",7
"R-HSA-111885","R-HSA-111885","Opioid Signalling","5/77","59/2914",0.0186014716461368,0.0645195603647941,0.0403906368416413,"PPP1CA/MAPK1/PRKACA/CAMK2A/CREB1",5
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","6/77","81/2914",0.0188481575283256,0.0645195603647941,0.0403906368416413,"CDK2/ATR/TP53/UBE2I/SUMO1/MAPK8",6
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","3/77","22/2914",0.0190352740206691,0.0645195603647941,0.0403906368416413,"GRB2/HRAS/SHC1",3
"R-HSA-1500620","R-HSA-1500620","Meiosis","3/77","22/2914",0.0190352740206691,0.0645195603647941,0.0403906368416413,"CDK2/ATR/UBE2I",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/77","22/2914",0.0190352740206691,0.0645195603647941,0.0403906368416413,"CTNNB1/MAPK14/TCF4",3
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","3/77","22/2914",0.0190352740206691,0.0645195603647941,0.0403906368416413,"GRB2/HRAS/PLCG1",3
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","3/77","22/2914",0.0190352740206691,0.0645195603647941,0.0403906368416413,"CDK2/TP53/MDM2",3
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","3/77","22/2914",0.0190352740206691,0.0645195603647941,0.0403906368416413,"CDK2/TP53/MDM2",3
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","3/77","22/2914",0.0190352740206691,0.0645195603647941,0.0403906368416413,"GRB2/HRAS/PLCG1",3
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","3/77","22/2914",0.0190352740206691,0.0645195603647941,0.0403906368416413,"PRKACA/CAMK2A/CREB1",3
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","4/77","40/2914",0.0200435728485618,0.0672294839295509,0.0420871074616182,"EP300/NCOA2/CREBBP/CEBPA",4
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","4/77","40/2914",0.0200435728485618,0.0672294839295509,0.0420871074616182,"SMAD3/EP300/CREBBP/FBXW7",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/77","23/2914",0.0214818348737507,0.0702248815162205,0.0439622909786081,"CDK1/MAP2K1/MAPK1",3
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/77","23/2914",0.0214818348737507,0.0702248815162205,0.0439622909786081,"EP300/TP53/CREBBP",3
"R-HSA-201451","R-HSA-201451","Signaling by BMP","3/77","23/2914",0.0214818348737507,0.0702248815162205,0.0439622909786081,"SMAD4/SMAD7/SMAD1",3
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","3/77","23/2914",0.0214818348737507,0.0702248815162205,0.0439622909786081,"UBE2I/PIAS1/SUMO1",3
"R-HSA-5654699","R-HSA-5654699","SHC-mediated cascade:FGFR2","3/77","23/2914",0.0214818348737507,0.0702248815162205,0.0439622909786081,"GRB2/HRAS/SHC1",3
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","4/77","41/2914",0.0217752463840523,0.0708245387440894,0.0443376893412655,"PRKACA/CAMK2A/CREB1/SGK1",4
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","7/77","108/2914",0.0224469872622842,0.0726425115422665,0.0454757795369207,"CSNK2A1/CTNNB1/EP300/CREBBP/GSK3B/TCF7/SOX6",7
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","5/77","62/2914",0.0226178808100906,0.0728295762084919,0.0455928860540248,"CDK1/CDK2/ATR/TP53/SUMO1",5
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","6/77","85/2914",0.023376925725919,0.0741264646979205,0.046404766229656,"CTNNB1/MAPK14/PRKACA/HRAS/PLCG1/RASA1",6
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","4/77","42/2914",0.0235961572407977,0.0741264646979205,0.046404766229656,"MAP2K1/MAPK1/CAMK2A/HRAS",4
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","4/77","42/2914",0.0235961572407977,0.0741264646979205,0.046404766229656,"MAP2K1/MAPK1/CAMK2A/HRAS",4
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","4/77","42/2914",0.0235961572407977,0.0741264646979205,0.046404766229656,"MAP2K1/MAPK1/CAMK2A/HRAS",4
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","4/77","42/2914",0.0235961572407977,0.0741264646979205,0.046404766229656,"MAP2K1/MAPK1/CAMK2A/HRAS",4
"R-HSA-1474165","R-HSA-1474165","Reproduction","3/77","24/2914",0.0240928135140631,0.0742381430768261,0.0464746793043877,"CDK2/ATR/UBE2I",3
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/77","24/2914",0.0240928135140631,0.0742381430768261,0.0464746793043877,"EP300/PAX6/CREBBP",3
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","3/77","24/2914",0.0240928135140631,0.0742381430768261,0.0464746793043877,"CDK2/TP53/RB1",3
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","3/77","24/2914",0.0240928135140631,0.0742381430768261,0.0464746793043877,"CDK2/TP53/MDM2",3
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","3/77","25/2914",0.0268682205670181,0.080604422404703,0.0504601075204335,"PRKACA/CAMK2A/CREB1",3
"R-HSA-111997","R-HSA-111997","CaM pathway","3/77","25/2914",0.0268682205670181,0.080604422404703,0.0504601075204335,"PRKACA/CAMK2A/CREB1",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/77","10/2914",0.0270350236636892,0.080604422404703,0.0504601075204335,"CDK1/MAP2K1",2
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","2/77","10/2914",0.0270350236636892,0.080604422404703,0.0504601075204335,"ATR/UBE2I",2
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","2/77","10/2914",0.0270350236636892,0.080604422404703,0.0504601075204335,"UBE2I/SUMO1",2
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","2/77","10/2914",0.0270350236636892,0.080604422404703,0.0504601075204335,"EP300/GSK3B",2
"R-HSA-8853334","R-HSA-8853334","Signaling by FGFR3 fusions in cancer","2/77","10/2914",0.0270350236636892,0.080604422404703,0.0504601075204335,"GRB2/HRAS",2
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","4/77","44/2914",0.0275095282042045,0.0808955989201264,0.0506423903014194,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","4/77","44/2914",0.0275095282042045,0.0808955989201264,0.0506423903014194,"ESR1/GRB2/HRAS/SHC1",4
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","4/77","44/2914",0.0275095282042045,0.0808955989201264,0.0506423903014194,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","4/77","45/2914",0.0296036127072549,0.0866578481066916,0.0542496826166441,"STAT3/GRB2/HRAS/PLCG1",4
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","4/77","46/2914",0.0317901860294163,0.090956212921781,0.0569405517310267,"MAP2K1/MAPK1/CAMK2A/HRAS",4
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","4/77","46/2914",0.0317901860294163,0.090956212921781,0.0569405517310267,"CDK1/ATR/TP53/SUMO1",4
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","2/77","11/2914",0.0324843617577789,0.090956212921781,0.0569405517310267,"CDK1/RB1",2
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/77","11/2914",0.0324843617577789,0.090956212921781,0.0569405517310267,"MAX/E2F4",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/77","11/2914",0.0324843617577789,0.090956212921781,0.0569405517310267,"EP300/CREB1",2
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","2/77","11/2914",0.0324843617577789,0.090956212921781,0.0569405517310267,"EP300/CREBBP",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/77","11/2914",0.0324843617577789,0.090956212921781,0.0569405517310267,"CDK2/TP53",2
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","2/77","11/2914",0.0324843617577789,0.090956212921781,0.0569405517310267,"ESR1/YY1",2
"R-HSA-9028731","R-HSA-9028731","Activated NTRK2 signals through FRS2 and FRS3","2/77","11/2914",0.0324843617577789,0.090956212921781,0.0569405517310267,"GRB2/HRAS",2
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","2/77","11/2914",0.0324843617577789,0.090956212921781,0.0569405517310267,"FOXO4/FOXO3",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","3/77","27/2914",0.0329105305378217,0.0911313342752502,0.0570501814766604,"CDK1/TP53/ESR1",3
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","3/77","27/2914",0.0329105305378217,0.0911313342752502,0.0570501814766604,"CCNH/KMT2A/GATA2",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","6/77","92/2914",0.0329714299474119,0.0911313342752502,0.0570501814766604,"CTNNB1/MAPK14/PRKACA/HRAS/PLCG1/RASA1",6
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","4/77","47/2914",0.0340697725821577,0.093365674650679,0.058448926759088,"CDK2/STAT3/HRAS/RASA1",4
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","4/77","47/2914",0.0340697725821577,0.093365674650679,0.058448926759088,"CDK2/STAT3/HRAS/RASA1",4
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","7/77","119/2914",0.0358058692800451,0.0977075415946992,0.0611670291447692,"CSNK2A1/EP300/NCOA2/PPP1CA/UBE2I/CREBBP/PRKACA",7
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","3/77","28/2914",0.0361756977878353,0.0983002083348773,0.0615380513113076,"NCOA2/UBE2I/CREBBP",3
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","4/77","48/2914",0.0364427848132903,0.0986098883183148,0.0617319176624952,"CDK2/ATR/UBE2I/SUMO1",4
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","10/77","202/2914",0.0376587618675701,0.100736765785003,0.0630633888454661,"CDK1/MAP2K1/MAPK1/PRKACA/CAMK2A/GRB2/HRAS/RASA1/SHC1/FOXO3",10
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","2/77","12/2914",0.0383237695921207,0.100736765785003,0.0630633888454661,"CAMK2A/CREB1",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/77","12/2914",0.0383237695921207,0.100736765785003,0.0630633888454661,"MAP2K1/MAPK1",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/77","12/2914",0.0383237695921207,0.100736765785003,0.0630633888454661,"STAT3/GRB2",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/77","12/2914",0.0383237695921207,0.100736765785003,0.0630633888454661,"EP300/CREBBP",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/77","12/2914",0.0383237695921207,0.100736765785003,0.0630633888454661,"CTNNB1/PAX6",2
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","2/77","12/2914",0.0383237695921207,0.100736765785003,0.0630633888454661,"PRKACA/CREB1",2
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/77","49/2914",0.0389095252316399,0.101448316798284,0.0635088351319756,"TP53/MAPK1/STAT3/MAPK8",4
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","4/77","49/2914",0.0389095252316399,0.101448316798284,0.0635088351319756,"MAP2K1/MAPK1/CAMK2A/HRAS",4
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/77","29/2914",0.0396018693401178,0.102424111867614,0.0641197038988168,"EP300/TP53/CREBBP",3
"R-HSA-5673000","R-HSA-5673000","RAF activation","3/77","29/2914",0.0396018693401178,0.102424111867614,0.0641197038988168,"MAP2K1/CAMK2A/HRAS",3
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","3/77","30/2914",0.0431874406703767,0.11125084716689,0.0696454306389653,"BCL6/TP53/CREBBP",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","2/77","13/2914",0.0445293980418485,0.111583394314982,0.0698536123286012,"PRKACA/CREB1",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/77","13/2914",0.0445293980418485,0.111583394314982,0.0698536123286012,"MAP2K1/MAPK1",2
"R-HSA-171007","R-HSA-171007","p38MAPK events","2/77","13/2914",0.0445293980418485,0.111583394314982,0.0698536123286012,"MAPK14/HRAS",2
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","2/77","13/2914",0.0445293980418485,0.111583394314982,0.0698536123286012,"GRB2/HRAS",2
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","2/77","13/2914",0.0445293980418485,0.111583394314982,0.0698536123286012,"GSK3B/MDM2",2
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","2/77","13/2914",0.0445293980418485,0.111583394314982,0.0698536123286012,"UBE2I/SUMO1",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/77","13/2914",0.0445293980418485,0.111583394314982,0.0698536123286012,"EP300/CREBBP",2
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","4/77","52/2914",0.0468735382589823,0.116243365330693,0.0727708547264718,"MAPK1/GRB2/HRAS/SHC1",4
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","4/77","52/2914",0.0468735382589823,0.116243365330693,0.0727708547264718,"MAPK1/GRB2/HRAS/SHC1",4
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/77","31/2914",0.0469305512204662,0.116243365330693,0.0727708547264718,"CTNNB1/TCF7/SOX6",3
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","5/77","76/2914",0.0486157220877891,0.118752571316189,0.0743416718112135,"CTNNB1/MAP3K7/CAMK2A/NFATC1/TCF7",5
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","3/77","32/2914",0.0508291042553943,0.118752571316189,0.0743416718112135,"NCOA2/CREBBP/CREB1",3
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","3/77","32/2914",0.0508291042553943,0.118752571316189,0.0743416718112135,"GRB2/HRAS/PLCG1",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","3/77","32/2914",0.0508291042553943,0.118752571316189,0.0743416718112135,"MAP2K1/MAPK1/HRAS",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"MAPK1/GRB2",2
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"NCOA2/CREBBP",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"CTNNB1/PAX6",2
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"CTNNB1/GSK3B",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"CTNNB1/GSK3B",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"CTNNB1/GSK3B",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"CTNNB1/GSK3B",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"CTNNB1/GSK3B",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"CTNNB1/GSK3B",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"EP300/TP53",2
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"PIAS1/SUMO1",2
"R-HSA-8849471","R-HSA-8849471","PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"HRAS/RASA1",2
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","2/77","14/2914",0.0510783575381745,0.118752571316189,0.0743416718112135,"EP300/CREBBP",2
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","7/77","130/2914",0.0536521399834799,0.124287691184752,0.0778067762728997,"CTNNB1/AR/NCOA2/MAPK1/MAPK14/GRB2/SRF",7
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/77","33/2914",0.0548807857440192,0.126678229459313,0.0793033048102598,"CDK1/MAPK1/RB1",3
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","2/77","15/2914",0.0579486850734449,0.129861791819408,0.0812962835351963,"GRB2/SHC1",2
"R-HSA-442982","R-HSA-442982","Ras activation upon Ca2+ influx through NMDA receptor","2/77","15/2914",0.0579486850734449,0.129861791819408,0.0812962835351963,"CAMK2A/HRAS",2
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","2/77","15/2914",0.0579486850734449,0.129861791819408,0.0812962835351963,"EP300/GSK3B",2
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","2/77","15/2914",0.0579486850734449,0.129861791819408,0.0812962835351963,"TP53/CREBBP",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/77","15/2914",0.0579486850734449,0.129861791819408,0.0812962835351963,"CDK1/E2F4",2
"R-HSA-69541","R-HSA-69541","Stabilization of p53","2/77","15/2914",0.0579486850734449,0.129861791819408,0.0812962835351963,"TP53/MDM2",2
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","2/77","15/2914",0.0579486850734449,0.129861791819408,0.0812962835351963,"CTNNB1/GRB2",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/77","15/2914",0.0579486850734449,0.129861791819408,0.0812962835351963,"SMAD3/STAT3",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","3/77","34/2914",0.0590830823029292,0.129861791819408,0.0812962835351963,"CTNNB1/EP300/CREBBP",3
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","3/77","34/2914",0.0590830823029292,0.129861791819408,0.0812962835351963,"EP300/NCOA2/CREBBP",3
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/77","34/2914",0.0590830823029292,0.129861791819408,0.0812962835351963,"MAP2K1/MAPK1/HRAS",3
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","3/77","34/2914",0.0590830823029292,0.129861791819408,0.0812962835351963,"MAP2K1/MAPK1/HRAS",3
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","3/77","34/2914",0.0590830823029292,0.129861791819408,0.0812962835351963,"CDK1/PRKACA/FOXO3",3
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/77","34/2914",0.0590830823029292,0.129861791819408,0.0812962835351963,"CCNH/ATR/TP53",3
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","3/77","35/2914",0.0634332982415821,0.138418654859587,0.0866530644184733,"MAPK14/MAPK8/PLCG1",3
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","3/77","35/2914",0.0634332982415821,0.138418654859587,0.0866530644184733,"GSK3B/PRKACA/SMO",3
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","5/77","82/2914",0.063620996643537,0.138418654859587,0.0866530644184733,"MAP2K1/SMAD3/MAP3K7/STAT3/MAPK8",5
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","2/77","16/2914",0.0651193122452296,0.138863698960026,0.0869316716274763,"CDK2/ATR",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/77","16/2914",0.0651193122452296,0.138863698960026,0.0869316716274763,"CTNNB1/GSK3B",2
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","2/77","16/2914",0.0651193122452296,0.138863698960026,0.0869316716274763,"GRB2/HRAS",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/77","16/2914",0.0651193122452296,0.138863698960026,0.0869316716274763,"MAPK1/MAPK14",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/77","16/2914",0.0651193122452296,0.138863698960026,0.0869316716274763,"CDK1/TP53",2
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","2/77","16/2914",0.0651193122452296,0.138863698960026,0.0869316716274763,"EP300/MDM2",2
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","4/77","59/2914",0.0687246431540265,0.146068218452782,0.0914418562723369,"CDK2/ATR/UBE2I/SUMO1",4
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","3/77","37/2914",0.0725658902321907,0.150758393854017,0.0943780072672253,"CTNNB1/GSK3B/TCF7",3
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/77","37/2914",0.0725658902321907,0.150758393854017,0.0943780072672253,"EP300/CREBBP/IKZF1",3
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","2/77","17/2914",0.0725700343086105,0.150758393854017,0.0943780072672253,"MDM2/CAMK2A",2
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","2/77","17/2914",0.0725700343086105,0.150758393854017,0.0943780072672253,"MDM2/CAMK2A",2
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","2/77","17/2914",0.0725700343086105,0.150758393854017,0.0943780072672253,"MAPK14/GNAQ",2
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","2/77","17/2914",0.0725700343086105,0.150758393854017,0.0943780072672253,"UBE2I/SUMO1",2
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","2/77","17/2914",0.0725700343086105,0.150758393854017,0.0943780072672253,"CCNH/SIRT1",2
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","3/77","38/2914",0.0773421049159736,0.160155355517322,0.100260708014276,"UBE2I/PIAS1/SUMO1",3
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","6/77","114/2914",0.0784126315454106,0.161851713830912,0.101322664918665,"CDK1/CDK2/ATR/TP53/MDM2/SUMO1",6
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","4/77","62/2914",0.0794588532071684,0.162966565176485,0.102020585914668,"STAT3/GRB2/HRAS/SHC1",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/77","62/2914",0.0794588532071684,0.162966565176485,0.102020585914668,"CDK2/TP53/PRKACA/GATA2",4
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","2/77","18/2914",0.0802814802067085,0.1630954992212,0.102101301408499,"GSK3B/PRKACA",2
"R-HSA-5658442","R-HSA-5658442","Regulation of RAS by GAPs","2/77","18/2914",0.0802814802067085,0.1630954992212,0.102101301408499,"HRAS/RASA1",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/77","18/2914",0.0802814802067085,0.1630954992212,0.102101301408499,"CSNK2A1/EP300",2
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","3/77","39/2914",0.08225394461106,0.166577170847556,0.104280902966024,"MAP3K7/HRAS/NFATC1",3
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","4/77","63/2914",0.0832138407815492,0.167467854572868,0.104838490195175,"CDK2/ATR/UBE2I/SUMO1",4
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","4/77","63/2914",0.0832138407815492,0.167467854572868,0.104838490195175,"MAP3K7/GRB2/HRAS/NFATC1",4
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","3/77","40/2914",0.0872980288080193,0.17405551254602,0.108962506219558,"EP300/CREBBP/FBXW7",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","3/77","40/2914",0.0872980288080193,0.17405551254602,0.108962506219558,"CCNH/RB1/E2F4",3
"R-HSA-69236","R-HSA-69236","G1 Phase","3/77","40/2914",0.0872980288080193,0.17405551254602,0.108962506219558,"CCNH/RB1/E2F4",3
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","2/77","19/2914",0.0882350835503391,0.174841211712057,0.10945437084949,"NCOA2/CREBBP",2
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","2/77","19/2914",0.0882350835503391,0.174841211712057,0.10945437084949,"GSK3B/PRKACA",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","8/77","177/2914",0.0924392659359003,0.18155867912652,0.11365965038486,"CDK1/MAP2K1/MAPK1/CAMK2A/GRB2/HRAS/RASA1/SHC1",8
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","3/77","41/2914",0.0924708800520166,0.18155867912652,0.11365965038486,"STAT3/GRB2/HRAS",3
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","3/77","41/2914",0.0924708800520166,0.18155867912652,0.11365965038486,"STAT3/GRB2/SHC1",3
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","2/77","20/2914",0.0964130545185165,0.186456477807581,0.116725778032533,"NCOA2/CREBBP",2
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","2/77","20/2914",0.0964130545185165,0.186456477807581,0.116725778032533,"MAP3K7/MAPK8",2
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","2/77","20/2914",0.0964130545185165,0.186456477807581,0.116725778032533,"PRKACA/CAMK2A",2
"R-HSA-5654706","R-HSA-5654706","FRS-mediated FGFR3 signaling","2/77","20/2914",0.0964130545185165,0.186456477807581,0.116725778032533,"GRB2/HRAS",2
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","2/77","20/2914",0.0964130545185165,0.186456477807581,0.116725778032533,"EP300/KMT2A",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","3/77","42/2914",0.0977689356528799,0.188512558564235,0.118012928947535,"CDK1/PRKACA/SMO",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","5/77","94/2914",0.100630567066822,0.193451000570248,0.121104500193536,"BCL6/TP53/STAT3/FOXO3/JUNB",5
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","2/77","21/2914",0.10479835265233,0.199674967775444,0.125000837950303,"MAP3K7/MAPK14",2
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","2/77","21/2914",0.10479835265233,0.199674967775444,0.125000837950303,"UBE2I/SUMO1",2
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","2/77","21/2914",0.10479835265233,0.199674967775444,0.125000837950303,"GRB2/HRAS",2
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","4/77","69/2914",0.10752589656604,0.204267484921918,0.127875852770668,"GRB2/HRAS/PLCG1/SHC1",4
"R-HSA-180024","R-HSA-180024","DARPP-32 events","2/77","22/2914",0.113374660515496,0.214744945211703,0.134434968970386,"PPP1CA/PRKACA",2
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","3/77","45/2914",0.114377651373214,0.216009406112464,0.135226548775864,"PRKACA/GRB2/SHC1",3
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/77","46/2914",0.120139567559991,0.226227723709457,0.141623436058715,"RARA/AR/ESR1",3
"R-HSA-392518","R-HSA-392518","Signal amplification","2/77","23/2914",0.122126358195662,0.228631903133739,0.143128504250118,"MAPK14/GNAQ",2
"R-HSA-5654693","R-HSA-5654693","FRS-mediated FGFR1 signaling","2/77","23/2914",0.122126358195662,0.228631903133739,0.143128504250118,"GRB2/HRAS",2
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","3/77","47/2914",0.126007962672116,0.234439369959165,0.14676410378287,"EP300/NCOA2/CREBBP",3
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","3/77","47/2914",0.126007962672116,0.234439369959165,0.14676410378287,"PIAS1/SUMO1/CAMK2A",3
"R-HSA-109581","R-HSA-109581","Apoptosis","5/77","101/2914",0.126320592198494,0.234439369959165,0.14676410378287,"CTNNB1/TP53/MAPK1/STAT3/MAPK8",5
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","2/77","24/2914",0.131038498621262,0.240423912000264,0.150510556221152,"EP300/CREBBP",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/77","24/2914",0.131038498621262,0.240423912000264,0.150510556221152,"STAT3/GRB2",2
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","2/77","24/2914",0.131038498621262,0.240423912000264,0.150510556221152,"AR/NCOA2",2
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","2/77","24/2914",0.131038498621262,0.240423912000264,0.150510556221152,"MAPK1/STAT3",2
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","3/77","48/2914",0.131978974529371,0.241461532945781,0.151160129320422,"EP300/NCOA2/CREBBP",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","5/77","103/2914",0.134176538827859,0.244786660071221,0.15324173064282,"CTNNB1/TP53/MAPK1/STAT3/MAPK8",5
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","2/77","25/2914",0.140096783669457,0.250617579675362,0.156892012121058,"GRB2/SHC1",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/77","25/2914",0.140096783669457,0.250617579675362,0.156892012121058,"CDK1/PRKACA",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/77","25/2914",0.140096783669457,0.250617579675362,0.156892012121058,"CDK1/PRKACA",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/77","25/2914",0.140096783669457,0.250617579675362,0.156892012121058,"MAPK1/GNAQ",2
"R-HSA-5654700","R-HSA-5654700","FRS-mediated FGFR2 signaling","2/77","25/2914",0.140096783669457,0.250617579675362,0.156892012121058,"GRB2/HRAS",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/77","25/2914",0.140096783669457,0.250617579675362,0.156892012121058,"MAPK1/GRB2",2
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","2/77","25/2914",0.140096783669457,0.250617579675362,0.156892012121058,"GRB2/SHC1",2
"R-HSA-68886","R-HSA-68886","M Phase","5/77","105/2914",0.142250105797478,0.253764731671954,0.158862197172865,"CDK1/CSNK2A1/MAPK1/PRKACA/RB1",5
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","7/77","165/2914",0.142739944474135,0.253935149837964,0.158968882621674,"RPS6KA1/RPS6KA2/MAPK1/GNAQ/CREB1/GRB2/HRAS",7
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/77","26/2914",0.149287541041392,0.260489060479932,0.163071772088614,"CDK1/PRKACA",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/77","26/2914",0.149287541041392,0.260489060479932,0.163071772088614,"CDK1/PRKACA",2
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","2/77","26/2914",0.149287541041392,0.260489060479932,0.163071772088614,"GRB2/SHC1",2
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","3/77","51/2914",0.150468836177849,0.260489060479932,0.163071772088614,"GRB2/HRAS/SHC1",3
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","3/77","51/2914",0.150468836177849,0.260489060479932,0.163071772088614,"GRB2/HRAS/SHC1",3
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","3/77","51/2914",0.150468836177849,0.260489060479932,0.163071772088614,"EP300/CREBBP/FBXW7",3
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","3/77","51/2914",0.150468836177849,0.260489060479932,0.163071772088614,"EP300/CREBBP/FBXW7",3
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","3/77","51/2914",0.150468836177849,0.260489060479932,0.163071772088614,"EP300/CREBBP/FBXW7",3
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","3/77","51/2914",0.150468836177849,0.260489060479932,0.163071772088614,"EP300/CREBBP/FBXW7",3
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","3/77","51/2914",0.150468836177849,0.260489060479932,0.163071772088614,"EP300/CREBBP/FBXW7",3
"R-HSA-109582","R-HSA-109582","Hemostasis","11/77","298/2914",0.157671136417167,0.270920212232893,0.169601898145142,"CDK2/TP53/MAPK1/MAPK14/PRKACA/GNAQ/GRB2/HRAS/PLCG1/SHC1/GATA2",11
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/77","27/2914",0.158597701881678,0.270920212232893,0.169601898145142,"CDK1/PRKACA",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/77","27/2914",0.158597701881678,0.270920212232893,0.169601898145142,"CDK1/PRKACA",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/77","27/2914",0.158597701881678,0.270920212232893,0.169601898145142,"MAPK1/GRB2",2
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","2/77","27/2914",0.158597701881678,0.270920212232893,0.169601898145142,"SMAD7/YY1",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","7/77","171/2914",0.162761380869128,0.277297167406662,0.173594009671055,"MAP2K1/MAPK1/CAMK2A/GRB2/HRAS/RASA1/SHC1",7
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/77","28/2914",0.168014779119666,0.283250046473991,0.177320640404607,"CDK1/PRKACA",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/77","28/2914",0.168014779119666,0.283250046473991,0.177320640404607,"MAPK1/GRB2",2
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","2/77","28/2914",0.168014779119666,0.283250046473991,0.177320640404607,"CCNH/EP300",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/77","28/2914",0.168014779119666,0.283250046473991,0.177320640404607,"EP300/CREBBP",2
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","3/77","55/2914",0.176322507507714,0.296479620979028,0.185602639481804,"GSK3B/PRKACA/SMO",3
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","2/77","29/2914",0.177526846510743,0.296953997799789,0.185899609606602,"TP53/MAPK8",2
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/77","29/2914",0.177526846510743,0.296953997799789,0.185899609606602,"EP300/CREB1",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","3/77","56/2914",0.182974471065122,0.305273469859945,0.191107778614513,"CDK1/CSNK2A1/PRKACA",3
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/77","30/2914",0.187122518356484,0.310584798509216,0.194432784944475,"CTNNB1/GSK3B",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/77","30/2914",0.187122518356484,0.310584798509216,0.194432784944475,"MAPK1/GRB2",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/77","31/2914",0.196790929883106,0.325792696258921,0.2039532570565,"CTNNB1/GSK3B",2
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","3/77","59/2914",0.203321808342201,0.335741652749686,0.210181518475204,"CSNK2A1/TP53/MAPK1",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/77","32/2914",0.206521718258287,0.3384223576548,0.211859697583832,"MAPK1/GRB2",2
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","2/77","32/2914",0.206521718258287,0.3384223576548,0.211859697583832,"CCNH/EP300",2
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","2/77","32/2914",0.206521718258287,0.3384223576548,0.211859697583832,"TP53/MAPK1",2
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/77","33/2914",0.216305004226949,0.351768744247867,0.220214823548436,"MAP3K7/MAPK14",2
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","2/77","33/2914",0.216305004226949,0.351768744247867,0.220214823548436,"CCNH/EP300",2
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","2/77","33/2914",0.216305004226949,0.351768744247867,0.220214823548436,"GRB2/SHC1",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/77","62/2914",0.224178104046819,0.363654153667888,0.227655346281139,"MAPK1/GRB2/PLCG1",3
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","7/77","188/2914",0.225783923709444,0.364071512698993,0.227916622039415,"MAP2K1/MAPK1/CAMK2A/GRB2/HRAS/RASA1/SHC1",7
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/77","34/2914",0.2261313743472,0.364071512698993,0.227916622039415,"CDK1/CDK2",2
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","2/77","34/2914",0.2261313743472,0.364071512698993,0.227916622039415,"HRAS/RASA1",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"MAPK1",1
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"RB1",1
"R-HSA-2025928","R-HSA-2025928","Calcineurin activates NFAT","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"NFATC1",1
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"NCOA2",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"SHC1",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"CREB1",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"TP53",1
"R-HSA-8875360","R-HSA-8875360","InlB-mediated entry of Listeria monocytogenes into host cell","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"GRB2",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"CSNK2A1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"STAT3",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/77","10/2914",0.235257100311538,0.367731972331627,0.230208148746344,"MAPK1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","2/77","35/2914",0.235991863808147,0.367987313056771,0.230367997549434,"PRKACA/CAMK2A",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","3/77","64/2914",0.238316679183311,0.370714834285151,0.23207548468652,"EP300/CREBBP/FBXW7",3
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","3/77","66/2914",0.252610037595684,0.379546720422476,0.23760443596242,"EP300/CREBBP/MAP3K1",3
"R-HSA-913531","R-HSA-913531","Interferon Signaling","4/77","97/2914",0.252964068838218,0.379546720422476,0.23760443596242,"PIAS1/SUMO1/CAMK2A/PLCG1",4
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"STAT3",1
"R-HSA-163615","R-HSA-163615","PKA activation","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"PRKACA",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"PAX6",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"PLCG1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"STAT3",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"TP53",1
"R-HSA-438066","R-HSA-438066","Unblocking of NMDA receptors, glutamate binding and activation","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"CAMK2A",1
"R-HSA-5210891","R-HSA-5210891","Uptake and function of anthrax toxins","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"MAP2K1",1
"R-HSA-5576892","R-HSA-5576892","Phase 0 - rapid depolarisation","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"CAMK2A",1
"R-HSA-5607763","R-HSA-5607763","CLEC7A (Dectin-1) induces NFAT activation","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"NFATC1",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"TP53",1
"R-HSA-73772","R-HSA-73772","RNA Polymerase I Promoter Escape","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"CCNH",1
"R-HSA-73863","R-HSA-73863","RNA Polymerase I Transcription Termination","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"CCNH",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"CDK1",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"GSK3B",1
"R-HSA-8875555","R-HSA-8875555","MET activates RAP1 and RAC1","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"GRB2",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/77","11/2914",0.255534374166914,0.379546720422476,0.23760443596242,"STAT3",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/77","37/2914",0.255781485502103,0.379546720422476,0.23760443596242,"CDK1/PRKACA",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"MAPK1",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"CSNK2A1",1
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"MAPK1",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"RUNX2",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"CDK1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"SHC1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"GRB2",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"CTNNB1",1
"R-HSA-5362517","R-HSA-5362517","Signaling by Retinoic Acid","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"RARA",1
"R-HSA-5620920","R-HSA-5620920","Cargo trafficking to the periciliary membrane","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"SMO",1
"R-HSA-5635838","R-HSA-5635838","Activation of SMO","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"SMO",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"CDK2",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"PRKACA",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"PRKACA",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"PRKACA",1
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"SHC1",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"CREB1",1
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","1/77","12/2914",0.275280792764622,0.390954109115547,0.244745707406431,"MAP3K7",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","2/77","39/2914",0.2756105054945,0.390954109115547,0.244745707406431,"CCNH/EP300",2
"R-HSA-983712","R-HSA-983712","Ion channel transport","2/77","39/2914",0.2756105054945,0.390954109115547,0.244745707406431,"CAMK2A/SGK1",2
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/77","40/2914",0.285521688478,0.402684689434973,0.252089303781619,"CDK1/CDK2",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/77","40/2914",0.285521688478,0.402684689434973,0.252089303781619,"CDK1/CDK2",2
"R-HSA-167160","R-HSA-167160","RNA Pol II CTD phosphorylation and interaction with CE during HIV infection","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"CCNH",1
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"MAPK8",1
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"GRB2",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"GSK3B",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"GSK3B",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"GSK3B",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"GSK3B",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"GSK3B",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"GSK3B",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"CTNNB1",1
"R-HSA-5654227","R-HSA-5654227","Phospholipase C-mediated cascade; FGFR3","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"PLCG1",1
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"EP300",1
"R-HSA-77075","R-HSA-77075","RNA Pol II CTD phosphorylation and interaction with CE","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"CCNH",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"CDK2",1
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","1/77","13/2914",0.294510075658187,0.402684689434973,0.252089303781619,"MAP3K7",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/77","42/2914",0.305304369649885,0.416559351810437,0.260775141783912,"CTNNB1/PAX6",2
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/77","14/2914",0.313235592436649,0.422900883709019,0.264745077575277,"NCOA2",1
"R-HSA-5654228","R-HSA-5654228","Phospholipase C-mediated cascade; FGFR4","1/77","14/2914",0.313235592436649,0.422900883709019,0.264745077575277,"PLCG1",1
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","1/77","14/2914",0.313235592436649,0.422900883709019,0.264745077575277,"MAP2K1",1
"R-HSA-72086","R-HSA-72086","mRNA Capping","1/77","14/2914",0.313235592436649,0.422900883709019,0.264745077575277,"CCNH",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/77","14/2914",0.313235592436649,0.422900883709019,0.264745077575277,"CAMK2A",1
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","2/77","43/2914",0.315163677498408,0.424613824914173,0.265817415727572,"MAPK1/GRB2",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","4/77","109/2914",0.324918580689013,0.433875852170547,0.271615644624583,"EP300/NCOA2/CREBBP/KMT2A",4
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","4/77","109/2914",0.324918580689013,0.433875852170547,0.271615644624583,"EP300/NCOA2/CREBBP/KMT2A",4
"R-HSA-113418","R-HSA-113418","Formation of the Early Elongation Complex","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"CCNH",1
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"GRB2",1
"R-HSA-167158","R-HSA-167158","Formation of the HIV-1 Early Elongation Complex","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"CCNH",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"CDK1",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"AR",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"PRKACA",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"CCNH",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"MAPK14",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"FOXO3",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"FOXO3",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"FBXW7",1
"R-HSA-9617324","R-HSA-9617324","Negative regulation of NMDA receptor-mediated neuronal transmission","1/77","15/2914",0.331470371534021,0.433875852170547,0.271615644624583,"CAMK2A",1
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","2/77","45/2914",0.334790151904709,0.437332368816699,0.273779498621765,"PRKACA/GNAQ",2
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","2/77","46/2914",0.344546996647651,0.449166530042686,0.281187938879289,"GRB2/HRAS",2
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/77","16/2914",0.34922710881994,0.449804516160083,0.281587331953762,"MAPK1",1
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","1/77","16/2914",0.34922710881994,0.449804516160083,0.281587331953762,"GRB2",1
"R-HSA-428930","R-HSA-428930","Thromboxane signalling through TP receptor","1/77","16/2914",0.34922710881994,0.449804516160083,0.281587331953762,"GNAQ",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/77","16/2914",0.34922710881994,0.449804516160083,0.281587331953762,"CSNK2A1",1
"R-HSA-5654219","R-HSA-5654219","Phospholipase C-mediated cascade: FGFR1","1/77","16/2914",0.34922710881994,0.449804516160083,0.281587331953762,"PLCG1",1
"R-HSA-6807004","R-HSA-6807004","Negative regulation of MET activity","1/77","16/2914",0.34922710881994,0.449804516160083,0.281587331953762,"GRB2",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","9/77","289/2914",0.353125342227938,0.453917605578427,0.28416221467234,"CSNK2A1/EP300/NCOA2/PPP1CA/UBE2I/CREBBP/PRKACA/GNAQ/PLCG1",9
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","2/77","48/2914",0.363924228170499,0.45921732554304,0.287479953715241,"MAP3K7/MAPK14",2
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"PRKACA",1
"R-HSA-167161","R-HSA-167161","HIV Transcription Initiation","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"CCNH",1
"R-HSA-167162","R-HSA-167162","RNA Polymerase II HIV Promoter Escape","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"CCNH",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"CDK1",1
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"GRB2",1
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"PLCG1",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"YY1",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"CDK2",1
"R-HSA-73776","R-HSA-73776","RNA Polymerase II Promoter Escape","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"CCNH",1
"R-HSA-73779","R-HSA-73779","RNA Polymerase II Transcription Pre-Initiation And Promoter Opening","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"CCNH",1
"R-HSA-75953","R-HSA-75953","RNA Polymerase II Transcription Initiation","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"CCNH",1
"R-HSA-76042","R-HSA-76042","RNA Polymerase II Transcription Initiation And Promoter Clearance","1/77","17/2914",0.366518175976899,0.45921732554304,0.287479953715241,"CCNH",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","5/77","153/2914",0.379688514577189,0.470249571167629,0.294386377504416,"MAPK1/MAPK14/GNAQ/GRB2/SHC1",5
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","2/77","50/2914",0.383091062014488,0.470249571167629,0.294386377504416,"GRB2/HRAS",2
"R-HSA-167152","R-HSA-167152","Formation of HIV elongation complex in the absence of HIV Tat","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"CCNH",1
"R-HSA-167169","R-HSA-167169","HIV Transcription Elongation","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"CCNH",1
"R-HSA-167200","R-HSA-167200","Formation of HIV-1 elongation complex containing HIV-1 Tat","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"CCNH",1
"R-HSA-167246","R-HSA-167246","Tat-mediated elongation of the HIV-1 transcript","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"CCNH",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"PLCG1",1
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"PRKACA",1
"R-HSA-5654221","R-HSA-5654221","Phospholipase C-mediated cascade; FGFR2","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"PLCG1",1
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"GRB2",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/77","18/2914",0.383355628669263,0.470249571167629,0.294386377504416,"MAX",1
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","7/77","228/2914",0.397613279442787,0.483909364932193,0.30293770312035,"CTNNB1/AR/NCOA2/MAPK1/MAPK14/GRB2/SRF",7
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/77","19/2914",0.399751214509203,0.483909364932193,0.30293770312035,"CDK1",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/77","19/2914",0.399751214509203,0.483909364932193,0.30293770312035,"CTNNB1",1
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","1/77","19/2914",0.399751214509203,0.483909364932193,0.30293770312035,"GRB2",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/77","19/2914",0.399751214509203,0.483909364932193,0.30293770312035,"CSNK2A1",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/77","19/2914",0.399751214509203,0.483909364932193,0.30293770312035,"CCNH",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/77","19/2914",0.399751214509203,0.483909364932193,0.30293770312035,"EP300",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","2/77","53/2914",0.411380734215486,0.494863861831755,0.309795454530177,"PRKACA/CAMK2A",2
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","2/77","53/2914",0.411380734215486,0.494863861831755,0.309795454530177,"MAP3K7/NFATC1",2
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","1/77","20/2914",0.415716380824502,0.494863861831755,0.309795454530177,"MAP2K1",1
"R-HSA-6783310","R-HSA-6783310","Fanconi Anemia Pathway","1/77","20/2914",0.415716380824502,0.494863861831755,0.309795454530177,"ATR",1
"R-HSA-70171","R-HSA-70171","Glycolysis","1/77","20/2914",0.415716380824502,0.494863861831755,0.309795454530177,"PRKACA",1
"R-HSA-70326","R-HSA-70326","Glucose metabolism","1/77","20/2914",0.415716380824502,0.494863861831755,0.309795454530177,"PRKACA",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/77","20/2914",0.415716380824502,0.494863861831755,0.309795454530177,"CCNH",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/77","20/2914",0.415716380824502,0.494863861831755,0.309795454530177,"CCNH",1
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","1/77","20/2914",0.415716380824502,0.494863861831755,0.309795454530177,"GRB2",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","4/77","126/2914",0.428604437391308,0.508668332890335,0.318437351253675,"CCNH/CTNNB1/MAP2K1/GRB2",4
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/77","55/2914",0.429895358316126,0.508668332890335,0.318437351253675,"PRKACA/GNAQ",2
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/77","21/2914",0.43126228223311,0.508668332890335,0.318437351253675,"CTNNB1",1
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","1/77","21/2914",0.43126228223311,0.508668332890335,0.318437351253675,"GRB2",1
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","1/77","21/2914",0.43126228223311,0.508668332890335,0.318437351253675,"MAP3K1",1
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","3/77","92/2914",0.441576789465031,0.517052991889922,0.323686328692122,"MAPK1/ESR1/GRB2",3
"R-HSA-112382","R-HSA-112382","Formation of RNA Pol II elongation complex ","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"CCNH",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"STAT3",1
"R-HSA-167172","R-HSA-167172","Transcription of the HIV genome","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"CCNH",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"CDK2",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"PRKACA",1
"R-HSA-5357956","R-HSA-5357956","TNFR1-induced NFkappaB signaling pathway","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"MAP3K7",1
"R-HSA-75955","R-HSA-75955","RNA Polymerase II Transcription Elongation","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"CCNH",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/77","22/2914",0.446399788029188,0.517052991889922,0.323686328692122,"EP300",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","2/77","57/2914",0.448107717669699,0.517170914299796,0.323760150664959,"CTNNB1/GRB2",2
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","2/77","57/2914",0.448107717669699,0.517170914299796,0.323760150664959,"MAP2K1/MAP3K7",2
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","1/77","23/2914",0.461139489385257,0.527484602422922,0.330216741954853,"GRB2",1
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","1/77","23/2914",0.461139489385257,0.527484602422922,0.330216741954853,"ATR",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/77","23/2914",0.461139489385257,0.527484602422922,0.330216741954853,"ATR",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/77","23/2914",0.461139489385257,0.527484602422922,0.330216741954853,"STAT3",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/77","23/2914",0.461139489385257,0.527484602422922,0.330216741954853,"CDK2",1
"R-HSA-202403","R-HSA-202403","TCR signaling","2/77","59/2914",0.465998802298913,0.532097923192376,0.333104780292056,"MAP3K7/PLCG1",2
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","1/77","24/2914",0.475491706374996,0.540064654154316,0.338092125761855,"MAP3K7",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/77","24/2914",0.475491706374996,0.540064654154316,0.338092125761855,"ATR",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/77","24/2914",0.475491706374996,0.540064654154316,0.338092125761855,"STAT3",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/77","25/2914",0.48946649482106,0.553868098513786,0.346733379749559,"CTNNB1",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/77","25/2914",0.48946649482106,0.553868098513786,0.346733379749559,"CSNK2A1",1
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","3/77","99/2914",0.490224869802574,0.553868098513786,0.346733379749559,"MAPK1/ESR1/GRB2",3
"R-HSA-182971","R-HSA-182971","EGFR downregulation","1/77","26/2914",0.503073652972247,0.564424098456667,0.353341663466661,"GRB2",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/77","26/2914",0.503073652972247,0.564424098456667,0.353341663466661,"CREBBP",1
"R-HSA-674695","R-HSA-674695","RNA Polymerase II Pre-transcription Events","1/77","26/2914",0.503073652972247,0.564424098456667,0.353341663466661,"CCNH",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/77","26/2914",0.503073652972247,0.564424098456667,0.353341663466661,"CTNNB1",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/77","27/2914",0.516322728014191,0.572079529522605,0.358134128485057,"ESR1",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/77","27/2914",0.516322728014191,0.572079529522605,0.358134128485057,"CDK1",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/77","27/2914",0.516322728014191,0.572079529522605,0.358134128485057,"MAP3K7",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/77","27/2914",0.516322728014191,0.572079529522605,0.358134128485057,"SUMO1",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/77","27/2914",0.516322728014191,0.572079529522605,0.358134128485057,"CDK2",1
"R-HSA-75893","R-HSA-75893","TNF signaling","1/77","27/2914",0.516322728014191,0.572079529522605,0.358134128485057,"MAP3K7",1
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","1/77","27/2914",0.516322728014191,0.572079529522605,0.358134128485057,"GRB2",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","6/77","217/2914",0.517003549972292,0.572079529522605,0.358134128485057,"PPP1CA/MAPK1/PRKACA/MTNR1A/CAMK2A/CREB1",6
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/77","28/2914",0.529223022417692,0.583595250748277,0.365343218431824,"CDK1",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/77","28/2914",0.529223022417692,0.583595250748277,0.365343218431824,"PRKACA",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/77","29/2914",0.541783600128655,0.594798687393207,0.372356811493295,"CDK1",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/77","29/2914",0.541783600128655,0.594798687393207,0.372356811493295,"SHC1",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","2/77","68/2914",0.54215346195623,0.594798687393207,0.372356811493295,"HRAS/RASA1",2
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/77","30/2914",0.554013292603557,0.605746282575027,0.379210242278907,"CSNK2A1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/77","30/2914",0.554013292603557,0.605746282575027,0.379210242278907,"CDK1",1
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/77","31/2914",0.565920704694239,0.614591793968111,0.384747723258886,"PRKACA",1
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/77","31/2914",0.565920704694239,0.614591793968111,0.384747723258886,"KMT2A",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/77","31/2914",0.565920704694239,0.614591793968111,0.384747723258886,"GRB2",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/77","31/2914",0.565920704694239,0.614591793968111,0.384747723258886,"MAPK14",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","2/77","72/2914",0.573558242850569,0.621837556221829,0.389283726761949,"ESR1/GRB2",2
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/77","32/2914",0.577514220385721,0.625074215005722,0.391309944993775,"STAT3",1
"R-HSA-5632684","R-HSA-5632684","Hedgehog 'on' state","1/77","33/2914",0.588802008390683,0.634094470574582,0.396956819598014,"SMO",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/77","33/2914",0.588802008390683,0.634094470574582,0.396956819598014,"ATR",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/77","33/2914",0.588802008390683,0.634094470574582,0.396956819598014,"CDK2",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/77","34/2914",0.599792027604122,0.6427056002946,0.40234757259371,"PLCG1",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/77","34/2914",0.599792027604122,0.6427056002946,0.40234757259371,"CDK1",1
"R-HSA-2672351","R-HSA-2672351","Stimuli-sensing channels","1/77","34/2914",0.599792027604122,0.6427056002946,0.40234757259371,"SGK1",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/77","35/2914",0.610492032421651,0.650921968343614,0.407491196266107,"PLCG1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/77","35/2914",0.610492032421651,0.650921968343614,0.407491196266107,"CTNNB1",1
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","1/77","35/2914",0.610492032421651,0.650921968343614,0.407491196266107,"TP53",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","11/77","436/2914",0.616965025295925,0.656736324447233,0.411131108635649,"PPP1CA/RPS6KA1/RPS6KA2/MAPK1/PRKACA/GNAQ/MTNR1A/CAMK2A/CREB1/GRB2/HRAS",11
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","1/77","36/2914",0.620909577924788,0.659844501953075,0.413076894815345,"GRB2",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","3/77","121/2914",0.62814501834126,0.666433923907366,0.417202015129979,"PRKACA/CAMK2A/SGK1",3
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/77","38/2914",0.640926544950394,0.677761403855589,0.42429326197563,"MAP3K7",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/77","38/2914",0.640926544950394,0.677761403855589,0.42429326197563,"GSK3B",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","12/77","486/2914",0.650918311482892,0.687199004254069,0.430201403447709,"PPP1CA/RPS6KA1/RPS6KA2/MAPK1/PRKACA/GNAQ/MTNR1A/CAMK2A/CREB1/GRB2/HRAS/SMO",12
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/77","42/2914",0.677882424136166,0.711003715217738,0.445103666113752,"GRB2",1
"R-HSA-162599","R-HSA-162599","Late Phase of HIV Life Cycle","1/77","42/2914",0.677882424136166,0.711003715217738,0.445103666113752,"CCNH",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/77","42/2914",0.677882424136166,0.711003715217738,0.445103666113752,"MAPK14",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/77","42/2914",0.677882424136166,0.711003715217738,0.445103666113752,"STAT3",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","7/77","296/2914",0.679929787115409,0.711991516914347,0.445722051288321,"MAP3K7/PRKACA/GRB2/HRAS/PLCG1/FBXW7/NFATC1",7
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/77","43/2914",0.686518584770398,0.717723974987234,0.44931069372362,"MAP3K7",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/77","44/2914",0.694926132305292,0.724162506803573,0.453341353556339,"CDK2",1
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","1/77","44/2914",0.694926132305292,0.724162506803573,0.453341353556339,"PRKACA",1
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","1/77","47/2914",0.718836071872467,0.74786822340205,0.468181643613902,"SRF",1
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","1/77","48/2914",0.726387387695913,0.75450560915511,0.472336790301417,"MAPK8",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/77","51/2914",0.74786070224477,0.774312366954392,0.484736248028003,"CDK2",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/77","51/2914",0.74786070224477,0.774312366954392,0.484736248028003,"FBXW7",1
"R-HSA-162587","R-HSA-162587","HIV Life Cycle","1/77","53/2914",0.761243132069637,0.783131912224994,0.490257473655072,"CCNH",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/77","53/2914",0.761243132069637,0.783131912224994,0.490257473655072,"CSNK2A1",1
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","1/77","53/2914",0.761243132069637,0.783131912224994,0.490257473655072,"GRB2",1
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","1/77","53/2914",0.761243132069637,0.783131912224994,0.490257473655072,"GRB2",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","2/77","106/2914",0.778778616772033,0.799893826477176,0.500750793626608,"MAP3K7/MAPK8",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","2/77","109/2914",0.79200136604463,0.812179744797359,0.508442043572064,"CCNH/MAPK14",2
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/77","61/2914",0.808111435865574,0.826069467773698,0.517137309835447,"MAPK8",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/77","61/2914",0.808111435865574,0.826069467773698,0.517137309835447,"CSNK2A1",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/77","64/2914",0.823237763059899,0.840198287496949,0.525982255821071,"PRKACA",1
"R-HSA-373080","R-HSA-373080","Class B/2 (Secretin family receptors)","1/77","65/2914",0.828013444549158,0.843735218812749,0.528196451136455,"SMO",1
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","1/77","66/2914",0.832661729831613,0.84713136494717,0.530322511890759,"GRB2",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/77","125/2914",0.851497515757042,0.864928075942484,0.541463636949937,"MAPK1/MAPK14",2
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/77","76/2914",0.872834421939206,0.885205303509997,0.55415761890214,"MAPK8",1
"R-HSA-162906","R-HSA-162906","HIV Infection","1/77","80/2914",0.88609048462775,0.897236276887218,0.561689267812691,"CCNH",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/77","88/2914",0.908644370953051,0.918629473930557,0.575081870734559,"FBXW7",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/77","115/2914",0.95681981581354,0.96581812129141,0.604622982109529,"FBXW7",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","1/77","144/2914",0.980850317972424,0.988525203089578,0.618838105235876,"GRB2",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","1/77","160/2914",0.987817766355235,0.993991627394955,0.622260204792854,"GRB2",1
"R-HSA-500792","R-HSA-500792","GPCR ligand binding","2/77","317/2914",0.998672395041907,1,0.626021575678326,"MTNR1A/SMO",2
"R-HSA-373076","R-HSA-373076","Class A/1 (Rhodopsin-like receptors)","1/77","248/2914",0.999035701465519,1,0.626021575678326,"MTNR1A",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","0/77","11/2914",1,1,0.626021575678326,"",0
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","0/77","14/2914",1,1,0.626021575678326,"",0
